FDA Hopes Revised Guidance Revives Interest In Testicular Implant Market
This article was originally published in The Gray Sheet
Executive Summary
FDA is hoping that an upcoming guidance containing less stringent trial design recommendations for testicular implant studies will incite more companies to seek agency approval for the products.